|
|
Post by Hot Christian Stocks on Mar 31, 2014 8:29:15 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Apr 1, 2014 8:01:17 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Apr 2, 2014 10:12:52 GMT -5
The first product $PLPL - Planda will bring to the market is Phytofare Catechin Complex, which includes the entire catechin profile derived from green tea. Stages 2 and 3 are also set up to process lemons, which will lead to the introduction of Phytofare Limonoid Glycoside Complex later in the year.Citrus bioflavonoids are highly regarded not only for treating cold and flu symptoms but also as a potent anti-inflammatory useful for soft-tissue injuries and sports recovery www.stockwatch.com/News/Item.aspx?bid=U-et1796556585-U%3aPLPL-20140401&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Apr 3, 2014 8:26:30 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Apr 4, 2014 7:40:27 GMT -5
$PLPL Closer to Unzipping the Magic of Phytofare in New Facility NEW YORK, NY -- (Marketwired) -- 04/04/14 Plandaí Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with a brand new state of the art production facility that is due to be fully operational sometime this month. Plandaí recently finished the all-important Stage 2 on the Senteeko Tea Estate in South Africa. It's this section of the factory that CEO Roger Duffield says "the magic of Phytofare" takes place. Plandaí will make its money and its mark in the biotechnology sector here as it's where the proprietary hydrodynamic sheering process will takes place. Plandaí and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. In order to develop these highly bioavailable extracts, it requires Plandaí's unique extraction process that uses live plant material grown on the tea estate and a combination of temperature and a unique wave of acoustic energy to release the living phytonutrients, rearranging the polyenes into a bio-compatible form. Plandaí's CEO said of this process, "The magic of Phytofare involves unzipping the molecule to release the valuable phytonutrients, which we have now done for the first time on an industrial scale." So, with stage 1 and 2 done, the company has turned to completing stage 3, the only section remaining between Plandaí and the introduction of its Phytofare extracts to the public. The third stage of Plandaí's process separates out the solids and any unnecessary elements, rendering pharmaceutical-grade, purified catechins in mainly nano-particle form. As Plandaí reaches the finish line on the production facility, Duffield said, "It is exciting to see the culmination of over ten years of research and effort on the part of countless supporters." www.stockwatch.com/News/Item.aspx?bid=U-i1104126-U%3aPLPL-20140404&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Apr 7, 2014 8:39:15 GMT -5
So, with stage 1 and 2 done, $PLPL - has turned to completing stage 3, the only section remaining between Plandaí and the introduction of its Phytofare extracts to the public. The third stage of Plandaí's process separates out the solids and any unnecessary elements, rendering pharmaceutical-grade, purified catechins in mainly nano-particle form www.stockwatch.com/News/Item.aspx?bid=U-i1104126-U%3aPLPL-20140404&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Apr 9, 2014 7:47:40 GMT -5
$PLPL - Planda first product to market will be Phytofare Catechin Complex, which includes the entire catechin profile derived from live green tea that is grown and processed on the Company's 8,000 acre Senteeko estate in South Africa. Later in 2014, and pending the results of a human clinical trial for treating cold and flu symptoms, the Company will begin producing Phytofare Limonoid Glycoside Complex, which contains citrus bioflavonoids that will also be extracted at the Senteeko facility using lemons bought from neighboring farms until its own lemon trees reach maturity. www.stockwatch.com/News/Item.aspx?bid=U-et971018422-U%3aPLPL-20140408&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Apr 10, 2014 8:25:18 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Apr 11, 2014 8:15:00 GMT -5
$PLPL Plandai Biotechnology's Cannabis Extracts Could Further Shape Marijuana Debate NEW YORK, NY -- (Marketwired) -- 04/11/14 Plandaí Biotechnology (OTCQB: PLPL) has a deal in place to brand and market its future cannabis extracts under the Diego Pellicer Gold label, and it could be those extracts and the company's work with cannabinoids that help shape public opinion in favor of using the drug medicinally. A Pew Research Center survey released last week found that 75 percent of Americans say they feel the legal sale and use of marijuana is inevitable whether they support it or not. While support for marijuana grows, Plandaí and its extracts could go a long way toward changing the minds of the drug's opponents. In the survey, 54 percent of respondents favored legalizing the use of marijuana which is a dramatic change from just 4 years ago when in the same survey, only 41 percent thought pot should be legal. Make no mistake about it attitudes are shifting in favor of marijuana in this country, and recent interest is likely due to CNN Chief Medical Correspondent Sanjay Gupta's "Weed" documentaries that are educating more Americans on the realities of cannabis. "Weed" documentaries can be seen commercial free at www.stockmarketmediagroup.com/media. Dr.Gupta himself was once a staunch opponent of legalizing marijuana, but he has since become a strong advocate for the use of cannabis. In those documentaries, Dr. Gupta has highlighted just how powerful the use of cannabinoids can be as a treatment for such things as seizures, pain management, cancer and many others. Plandaí produces highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, and will explore the use of both THC and cannabinoids to develop extracts and to pursue various pharmaceutical and nutraceutical applications. Dr. Gupta and a majority of Americans in general agree with Plandaí's CEO Roger Duffield who said, "The medicinal opportunities associated with phyto-cannabinoids are simply too great to ignore." www.stockwatch.com/News/Item.aspx?bid=U-i1106142-U%3aPLPL-20140411&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Apr 28, 2014 8:10:18 GMT -5
|
|
